-
We’re rebooting our Journal Club series! Going forward, these episodes will be interspersed in our regular feed. In this episode, Ben Cravatt, Professor in the Department of Chemistry at the Scripps Research Instit...
-
Kevin Parker, cofounder and CEO of Cartography Biosciences, joins Jorge Conde, general partner at a16z Bio + Health, and Olivia Webb, editorial lead.
-
The RNA technology underlying both the Moderna and Pfizer/BioNTech vaccines could give us our fastest ticket out of the COVID-19 pandemic. With their rapid development and the early signs of success, RNA-based therapeuti...
-
The entire healthcare system is built around the idea that we can detect, diagnose, and manage disease effectively for patients. This pandemic has been a stress test of that capability, and we have roundly failed that te...
-
There’s been a lot of talk lately about possibilities for treating aging—from blood transfusions from old mice to young, to eradicating “zombie” cells, to taking daily rapamycin and metformin pills to extend your...
-
The FDA just approved the first ever videogame that can now be legally marketed and prescribed as a medicine. It’s a game called EndeavorRX (formerly known as Project EVO and developed by Akili Interactive based on...
-
a16z Journal Club (part of the a16z Podcast), curates and covers recent advances from the scientific literature — what papers we’re reading, and why they matter from our perspective at the intersection of biology...
-
1/ RCTs vs RWE’s has become a heated debate. Some believe that RWE would be cheaper and better, as there’s more data. Others believe that RCTs are the only statistically validated means to test a drug. Who’s right?